Literature DB >> 21723283

Epigenetic regulation of microRNA-375 and its role in melanoma development in humans.

Joseph Mazar1, Dan DeBlasio, Subramaniam S Govindarajan, Shaojie Zhang, Ranjan J Perera.   

Abstract

To identify epigenetically regulated miRNAs in melanoma, we treated a stage 3 melanoma cell line WM1552C, with 5AzadC and/or 4-PBA. Several hypermethylated miRNAs were detected, one of which, miR-375, was highly methylated and was studied further. Minimal CpG island methylation was observed in melanocytes, keratinocytes, normal skin, and nevus but hypermethylation was observed in patient tissue samples from primary, regional, distant, and nodular metastatic melanoma. Ectopic expression of miR-375 inhibited melanoma cell proliferation, invasion, and cell motility, and induced cell shape changes, strongly suggesting that miR-375 may have an important function in the development and progression of human melanomas.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723283     DOI: 10.1016/j.febslet.2011.06.025

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  35 in total

Review 1.  Circulating epigenetic biomarkers in melanoma.

Authors:  Yu Xin; Zheng Li; Matthew T V Chan; William Ka Kei Wu
Journal:  Tumour Biol       Date:  2015-12-11

Review 2.  Epigenetic biomarkers in skin cancer.

Authors:  Edward S Greenberg; Kelly K Chong; Kelly T Huynh; Ryo Tanaka; Dave S B Hoon
Journal:  Cancer Lett       Date:  2012-01-27       Impact factor: 8.679

Review 3.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

Authors:  Muhammad Nauman Aftab; Marcel E Dinger; Ranjan J Perera
Journal:  Arch Biochem Biophys       Date:  2014-07-24       Impact factor: 4.013

4.  MicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell Carcinoma.

Authors:  Lizandra Jimenez; Ved P Sharma; John Condeelis; Thomas Harris; Thomas J Ow; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Arch Pathol Lab Med       Date:  2015-07-14       Impact factor: 5.534

Review 5.  Epigenetic markers in melanoma.

Authors:  Weimin Guo; Ting Xu; Jonathan J Lee; George F Murphy; Christine G Lian
Journal:  Melanoma Manag       Date:  2015-11-24

Review 6.  DNA methylation and microRNA dysregulation in cancer.

Authors:  Hiromu Suzuki; Reo Maruyama; Eiichiro Yamamoto; Masahiro Kai
Journal:  Mol Oncol       Date:  2012-08-10       Impact factor: 6.603

7.  There is a world beyond protein mutations: the role of non-coding RNAs in melanomagenesis.

Authors:  Rolf K Swoboda; Meenhard Herlyn
Journal:  Exp Dermatol       Date:  2013-03-12       Impact factor: 3.960

Review 8.  MicroRNAs in cancer diagnosis and therapy: from bench to bedside.

Authors:  Isamu Hoshino; Hisahiro Matsubara
Journal:  Surg Today       Date:  2012-11-06       Impact factor: 2.549

9.  Endobronchial miRNAs as biomarkers in lung cancer chemoprevention.

Authors:  Celine Mascaux; William J Feser; Marina T Lewis; Anna E Barón; Christopher D Coldren; Daniel T Merrick; Timothy C Kennedy; John I Eckelberger; Leslie M Rozeboom; Wilbur A Franklin; John D Minna; Paul A Bunn; York E Miller; Robert L Keith; Fred R Hirsch
Journal:  Cancer Prev Res (Phila)       Date:  2012-12-26

Review 10.  MicroRNA-Directed Cancer Therapies: Implications in Melanoma Intervention.

Authors:  Anita Thyagarajan; Ahmed Shaban; Ravi Prakash Sahu
Journal:  J Pharmacol Exp Ther       Date:  2017-10-20       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.